What is the role of DPP-4 in the use of Sitagliptin?

Study for the UWorld Pharmacology Test. Use flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam!

Sitagliptin is a medication used to manage type 2 diabetes, and it functions as a DPP-4 inhibitor. DPP-4, or dipeptidyl peptidase-4, is an enzyme that breaks down incretin hormones, including GLP-1 (glucagon-like peptide-1). By inhibiting the action of DPP-4, sitagliptin effectively prevents the degradation of GLP-1, leading to increased levels of this hormone in the bloodstream.

GLP-1 plays a critical role in glucose metabolism; it enhances insulin secretion from the pancreas in a glucose-dependent manner, suppresses glucagon secretion (which reduces glucose production by the liver), and contributes to feelings of satiety. Therefore, the inhibition of DPP-4 by sitagliptin promotes better glycemic control through sustained activity of GLP-1.

Understanding this mechanism highlights the importance of DPP-4 in the context of sitagliptin therapy, as targeting this enzyme enhances the hormone's beneficial effects on blood sugar regulation, improving overall diabetes management.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy